Molecular Testing – Why Is Reimbursement Lacking?

Molecular diagnostic assays are one of the fastest growing segments for clinical diagnostics. Advancements in testing capabilities allows for rapid determination by simultaneously assessing multiple genes, which for some patients will have life changing effects, by identification of low prevalence inherited and environmentally induced diseases, syndromes and conditions.

The advancements in testing capabilities are exciting for clinical outcomes, the unfortunate flip side of these advancements is the fact that the issuance of codes, guidelines